Resistin

Resistin is a small, cysteine-rich, secreted peptide hormone discovered in humans and other rodents and mammals. It plays a role in the regulation of glucose and lipid metabolism and is associated with obesity, insulin resistance, and type 2 diabetes mellitus. Resistin has been identified as a key component of the inflammatory response of macrophages, in the control of cell proliferation and is involved in the regulation of bone homeostasis. It is also known to be involved in numerous physiological processes, including immunity and inflammation, cell growth and differentiation, and obesity. Resistin is found in adipose tissue, where it is thought to regulate fat storage, and in the brain and liver, where it plays a role in energy homeostasis. Its significance lies in its ability to regulate metabolism, inflammation, and immunity, as well as its potential as a therapeutic target for treating obesity and diabetes.

← Journal of Obesity Management

Related Articles

1 journal(s) found

Obesity Management

ISSN: 2574-450X
Type: Open Access Journal
Editor-in-Chief: Amit Surve, Research Specialist, Bariatric Medicine Institute Surgical & Medical Weight Loss Solutions, Utah, USA.
JOM focuses on the research of eating disorders, habits and lifestyle of obese people. It aims to form a primary source for examining, diagnosing, treating and thus leading to a much healthier prospectus of obesity affected persons. Hoping that this helps clinicians all over the world to share their experiences and also to gain current information.